Skip to main content
Take Solutions Ltd logo

Take Solutions Ltd — Investor Relations & Filings

Ticker · TAKE ISIN · INE142I01023 LEI · 335800K65UFX9GOGC981 BSE.NS Professional, scientific and technical activities
Filings indexed 900 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country IN India
Listing BSE.NS TAKE

About Take Solutions Ltd

https://www.takesolutions.com/

Take Solutions Ltd provides specialized domain-led technology and services, primarily focusing on the Life Sciences sector. Through its key brand, Navitas Life Sciences, the company delivers end-to-end solutions across clinical research, regulatory affairs, and pharmacovigilance. Its service offerings include clinical data management, medical writing, and trial monitoring, leveraging proprietary platforms to enhance operational efficiency. The organization supports pharmaceutical, biotechnology, and medical device companies in managing complex regulatory requirements and streamlining the drug development process. By combining deep functional expertise with digital transformation capabilities, Take Solutions facilitates data-driven decision-making and ensures compliance with global safety standards. Its portfolio encompasses strategic consulting and technology-enabled services designed to optimize clinical trial outcomes and accelerate time-to-market for new therapies.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is a Regulation 30 SEBI stock exchange filing notifying the outcome of a Board Meeting, including corporate actions (name change, MOA amendments, auditor appointments, postal ballot notice). It does not contain financial statements (so not an Interim or Annual Report), nor is it a vote result disclosure or dividend notice. It is a general regulatory announcement that does not neatly fit into more specific categories, making ‘Regulatory Filings (RNS)’ the appropriate classification.
2026-05-13 English
Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum ....
Regulatory Filings Classification · 85% confidence The document is an official SEBI LODR Regulation 30 announcement detailing the outcome of the Board Meeting held on May 13, 2026, including corporate actions (name change, MOA amendments, auditor appointment, postal ballot approval, etc.). It does not itself contain financial statements, transcripts, or confer a report; nor is it announcing an AGM outcome or voting results. It is a general regulatory filing announcing board meeting decisions. Therefore it falls under the fallback category Regulatory Filings (RNS).
2026-05-13 English
Press Release
Regulatory Filings
2026-04-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-13 English
Press Release
Regulatory Filings
2026-04-06 English
Change in Auditors
Regulatory Filings
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.